Skip to main content Skip to main navigation menu Skip to site footer
PAGEPress
  • Bluesky
  • X
  • LinkedIn
Confinia Cephalalgica
  • Search
  • Contacts
  • News
  • Register
  • Login
  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current
  • Archives
  • Copyright
  • Search
  • Contacts
  • News
  • Register
  • Login
  1. Home /
  2. Search

Search

Advanced filters Clear filters
Published After
Published Before

Search Results

4 results for “G. Giuliani”

  • P109 | THE ROLE OF NEUROTICISM AND DEPRESSIVE SYMPTOMS IN MODULATING MIGRAINE BURDEN: A CROSS-SECTIONAL STUDY

    I. Getuli, R. Serra, L. Contento, G. Giuliani, C. Zilli, L. Tarsitani, M. Altieri | Departiment of Human Neuroscience, Policlinico Umberto I Hospital, Sapienza University of Rome, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.16065

    • 0 abstract views
    • 0 PDF
  • P027 | LONG-TERM RESPONSE AND TREATMENT PERSISTENCE IN THE ANTI-CGRP ERA: A REAL-WORLD STUDY

    G. Giuliani, C. Cutrona, A. Salerno | Headache Center, San Giovanni Addolorata Hospital, Rome, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15983

    • 0 abstract views
    • 0 PDF
  • OC18 | LONG-TERM EFFECTIVENESS, SAFETY AND TOLERABILITY OF ATOGEPANT IN THE PREVENTION OF MIGRAINE: A MULTICENTRIC, PROSPECTIVE OBSERVATIONAL, REAL WORLD STUDY (THE 48-WEEK STAR STUDY)

    F. Vernieri1|2, L. Francesco Iannone3, M. Marcosano1|2, L. Fofi1, F. Lo Castro4, G. Sebastianelli5, F. De Santis6, M. Corrado7, R. Ornello6, L. Grazzi8, D. Antonio Montisano8, F. De Cesaris9, A. Munafò9, G. Avino10, M. Trimboli11, M. Albanese12, A. Russo13, M. Silvestro13, G. Dalla Volta14, M. Romozzi15, P. Calabresi15, A. Boccalini4, P. Merlo16, M. Pia Prudenzano17, M. Rosaria Valente18, I. Rainero19, G. Giuliani20, M. Altieri20, A. Doretti21, G. Vaghi7|22, F. Pistoia6, D. Ferrandi23, S. Battistini24, G. Coppola5, S. Guerzoni4, S. Sacco6|25, C. Tassorelli7|22, C. Altamura1|2 | 1Headache and Neurosonology Unit, Fondazione Policlinico Universitario Campus Bio-Medico, Roma, Italy; 2Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Italy; 3Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Italy; 4Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, AOU Policlinico Di Modena, Italy; 5Sapienza University of Rome, Department of Medico-Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; 6Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, Italy; 7Headache Science and Neurorehabilitation Centre, IRCCS Mondino Foundation, Pavia, Italy; 8Headache Center IRCCS Fondazione Istituto Neurologico "Carlo Besta", Italy; 9Headache center and clinical pharmacology, AOU Careggi, Firenze, Italy; 10Neurology Unit, Ospedale Santo Stefano, USL Toscana Centro, Prato, Italy; 11Azienda Ospedaliera-universitaria "Renato Dulbecco", Catanzaro, Italy; 12Department of Systems Medicine, University of Rome Tor Vergata, Italy; 13Headache Center, Department of Medical, Surgical, Neurological, Metabolic and Aging Sciences, Second University of Naples, Italy; 14U.O Neurologia, Istituto Clinico Città di Brescia, Gruppo San Donato, Italy; 15Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy; 16UO di Neurologia, Humanitas Gavazzeni, Bergamo, Italy; 17Clinica Neurologica "L. Amaducci", Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Italy; 18Clinica Neurologica ASUFC, Dipartimento di Medicina DMED Università di Udine, Italy; 19Headache Center, Department of Neuroscience, University of Torino, Italy; 20Department of Human Neuroscience, Sapienza University of Rome, Italy; 21IRCCS Istituto Auxologico Italiano, Milano, Italy; 22Department of Brain and Behavioural Sciences, University of Pavia, Italy; 23SC Neurologia, Azienda Ospedaliero Universitaria Santi Antonio e Biagio, Alessandria, Italy; 24Department of Medical, Surgical and Neurological Sciences, University of Siena, Italy; 25Neurology and Stroke Unit, ASL 1 Abruzzo, Avezzano-Sulmona-L’Aquila, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15956

    • 0 abstract views
    • 0 PDF
  • P022 | REAL-WORLD CGRP-TARGETED THERAPY OUTCOMES IN HIGH-FREQUENCY MIGRAINE: IMPLICATIONS FOR THE 2025 POSITION STATEMENT OF HIS

    A. D'Amico1|2, B. Pitzalis3, C. Zilli3, G. Giuliani4, M. Di Giulio3, F. Traccitto3, M. Altieri3 | 1Istituto Neurotraumatologico Italiano - Roma, Italy; 2Dipartimento di Medicina, Chirurgia e Odontoiatria "Scuola Medica Salernitana", Università degli Studi di Salerno - Baronissi, Italy; 3Dipartimento di Neuroscienze Umane, Università degli Studi di Roma "La Sapienza", Italy; 4Centro Cefalee, Ospedale "San Giovanni Addolorata", Roma, Italy

    03-11-2026

    DOI https://doi.org/10.4081/cc.2026.15978

    • 2 abstract views
    • 0 PDF
1 - 4 of 4 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

Categories

    • Contents

indexing

INDEXING
  • Scopus
  • OpenAlex
  • Analytics

Keywords

Confinia Cephalalgica

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS. eISSN 3035-0670 (Website continuously updated).

pISSN 1122-0279
eISSN 3035-0670

The journal

  • About the Journal
  • Editorial board
  • Archives
  • Announcements
  • Contact

For authors

  • Submissions
  • Guidelines for authors
  • Privacy Statement
PAGEPress

© PAGEPress 2008–2026. PAGEPress® is a registered trademark property of PAGEPress srl, Italy. VAT IT02125780185. This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.